Related Experiment Video
Updated: May 2, 2026

04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.8K
Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease
The Journal of Clinical Investigation
|November 1, 1985
Summary
Maternal serum contained multiple thyroid antibodies, including thyroid-stimulating antibody (TSAb), a TSH-binding inhibitor, and a TSH-binding enhancer. Antibody concentration determines neonatal hyperthyroidism or TSH-binding effects.
Area of Science:
- Endocrinology
- Immunology
- Thyroid Research
Background:
- Investigated maternal serum from a woman with children exhibiting delayed hyperthyroidism.
- Examined the coexistence of thyroid-stimulating antibody (TSAb) and TSAb inhibitors in maternal serum.
Observation:
- Utilized human thyroid slices, cultured cells, and rat thyroid cells (FRTL5) for TSAb assays.
- Assessed TSH-binding inhibition using various cell membranes and receptors.
- Identified three distinct antibody activities within the immunoglobulin G (IgG) kappa fraction.
Findings:
- Detected TSAb, a potent inhibitor of TSH-binding across species, and a TSH-binding enhancer specific to human thyroid membranes.
- Demonstrated that the inhibitor and enhancer activities were mediated by F(ab')2 and Fab fragments of IgG.
- Proposed that IgG concentration dictates the balance between thyroid stimulation and TSH-binding modulation.
Implications:
- Suggests that the interplay of multiple thyroid antibodies in maternal serum can influence neonatal thyroid function.
- Highlights the potential for both stimulatory and inhibitory antibodies to coexist and impact thyroid hormone regulation.
- Underscores the need for further research into the prevalence and clinical significance of these complex antibody interactions.
Related Concept Videos
The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Hyperthyroidism I: Introduction
30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26

